Vijaya Diagnostic Centre share news, announcements and annual reports
NSE: VIJAYABSE: 543350Healthcare ServicesSmall Cap
Vijaya Diagnostic Centre Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2021 · Issue price ₹531
Last close ₹1,445.70down ₹18.50 (1.26%)BSE ₹1,447.25
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,464.20.
30 Oct: open ₹1,446.10, high ₹1,478.90, low ₹1,435.10
52-week range of traded prices to 30 Oct 2026
₹848.00Low, 30 Mar 2026₹1,593.60High, 23 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14,890 Cr523rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 79.42
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 15.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.14%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 21.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 27.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 50,16144.8% delivered
Vijaya Diagnostic Centre share news and announcements
318 announcements, routine notices left out, newest first. Page 2 of 7.
Feb 2026
13 Feb · Results
13 Feb · Board meeting
9 Feb · Analysts
6 Feb · Board meeting
Jan 2026
28 Jan · Analysts
Dec 2025
5 Dec · Legal
The exchange asked on 4 Dec 2025
Nov 2025
24 Nov · Analysts
4 Nov · Amendment to AOA/MOA
4 Nov · Results
4 Nov · Board meeting
Oct 2025
29 Oct · Analysts
27 Oct · Board meeting
18 Oct · Business
16 Oct · Business
8 Oct
Sep 2025
29 Sep · Business
Aug 2025
13 Aug
13 Aug
Jul 2025
30 Jul · Analysts
28 Jul · Disclosure
28 Jul · Results
28 Jul · Board meeting
18 Jul · Analysts
18 Jul · Board meeting
17 Jul · Analysts
File name: “Stx_Intimation_Signed”
Jun 2025
May 2025
13 May · Analysts
12 May · Disclosure